Chloroquine/hydroxychloroquine: an inflammasome inhibitor in severe COVID-19?

Chloroquine and hydroxychloroquine belong to the aminoquinoline drugs. Studies revealed that chloroquine and hydroxychloroquine shows antagonism activity against COVID-19 under laboratory conditions. ARDS and ALI are conditions that occur in patients with COVID-19 as the main pathological complicati...

Full description

Saved in:
Bibliographic Details
Published in:Naunyn Schmiedebergs Arch Pharmacol
Main Authors: Bahadoram, Mohammad, Keikhaei, Bijan, Saeedi-Boroujeni, Ali, Mahmoudian-Sani, Mohammad-Reza
Format: Artigo
Language:Inglês
Published: Springer Berlin Heidelberg 2021
Subjects:
Brief Communication
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7792551/
https://ncbi.nlm.nih.gov/pubmed/33416933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00210-020-02034-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items